首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   13858篇
  免费   941篇
  国内免费   34篇
耳鼻咽喉   99篇
儿科学   368篇
妇产科学   255篇
基础医学   2020篇
口腔科学   245篇
临床医学   1512篇
内科学   2702篇
皮肤病学   222篇
神经病学   1543篇
特种医学   394篇
外科学   1376篇
综合类   189篇
一般理论   12篇
预防医学   1522篇
眼科学   332篇
药学   992篇
中国医学   16篇
肿瘤学   1034篇
  2023年   92篇
  2022年   146篇
  2021年   232篇
  2020年   218篇
  2019年   269篇
  2018年   296篇
  2017年   250篇
  2016年   312篇
  2015年   358篇
  2014年   427篇
  2013年   615篇
  2012年   874篇
  2011年   993篇
  2010年   499篇
  2009年   492篇
  2008年   794篇
  2007年   807篇
  2006年   793篇
  2005年   812篇
  2004年   709篇
  2003年   712篇
  2002年   670篇
  2001年   269篇
  2000年   232篇
  1999年   221篇
  1998年   179篇
  1997年   134篇
  1996年   112篇
  1995年   106篇
  1994年   122篇
  1993年   104篇
  1992年   146篇
  1991年   123篇
  1990年   124篇
  1989年   119篇
  1988年   99篇
  1987年   104篇
  1986年   105篇
  1985年   92篇
  1984年   75篇
  1983年   75篇
  1982年   72篇
  1981年   56篇
  1979年   78篇
  1978年   56篇
  1977年   52篇
  1976年   59篇
  1974年   54篇
  1973年   46篇
  1972年   45篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
3.
The identification of EGFR mutations in non‐small‐cell lung cancer is important for selecting patients, who may benefit from treatment with EGFR tyrosine kinase inhibitors. The analysis is usually performed on cytological aspirates and/or histological needle biopsies, representing a small fraction of the tumour volume. The aim of the present investigation was to evaluate the diagnostic performance of this molecular test. We retrospectively included 201 patients with primary adenocarcinoma of the lung. EGFR mutation status (exon 19 deletions and exon 21 L858R point mutation) was evaluated on both pre‐operative biopsies (131 histological and 70 cytological) and on the surgical specimens, using PCR. Samples with low tumour cell fraction were assigned to laser micro‐dissection (LMD). We found nine (4.5%) patients with EGFR mutation in the lung tumour resections, but failed to identify mutation in one of the corresponding pre‐operative, cytological specimens. Several (18.4%) analyses of the pre‐operative biopsies were inconclusive, especially in case of biopsies undergoing LMD and regarding exon 21 analysis. Discrepancy of mutation status in one patient may reflect intra‐tumoural heterogeneity or technical issues. Moreover, several inconclusive results in the diagnostic biopsies reveal that attention must be paid on the suitability of pre‐operative biopsies for EGFR mutation analysis.  相似文献   
4.
5.
The European Journal of Health Economics - The aims of this study were to assess whether there is a conceptual overlap between the questionnaires HIT-6 and EQ-5D and to develop a mapping algorithm...  相似文献   
6.
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - Gefahrstoffe sind in der Arbeitswelt allgegenwärtig. Beschäftigte aus allen Branchen sind bei ihrer Arbeit mit...  相似文献   
7.
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号